Jyong Biotech (MENS) Balance Sheet: Assets & Liabilities

Jyong Biotech (MENS) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Jyong Biotech reported total assets of $20.78M and total liabilities of $45.68M. Shareholders' equity was negative at −$24.91M, meaning liabilities exceed assets. Total debt stood at $17.87M against $1.18M in cash and short-term investments, a net debt position of $16.70M.

Jyong Biotech Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Jyong Biotech Ltd. (MENS) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	1.18	0.10	0.18	0.72	0.55	3.56
Short-Term Investments	0.00	0.00	0.00	0.09	1.83	0.66
Cash & Short-Term Investments	1.18	0.10	0.18	0.81	2.39	4.22
Accounts Receivable	13.51	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.86	0.11	1.66	0.10	0.26	2.00
Total Current Assets	15.54	0.21	1.84	2.46	2.65	6.22
Non-Current Assets
Property, Plant & Equipment (Net)	3.15	3.19	3.54	6.00	6.78	6.61
Other Non-Current Assets	2.08	2.04	2.87	0.01	0.01	0.01
Total Non-Current Assets	5.24	6.16	6.41	6.28	6.78	6.62
Total Assets	20.78	6.37	8.25	8.75	9.43	12.84
Current Liabilities
Accounts Payable	0.00	0.00	0.00	0.00	0.05	0.03
Short-Term Debt	7.71	7.28	7.90	7.65	4.93	4.66
Current Portion of Long-Term Debt	0.57	0.06	0.08	0.48	0.18	0.17
Accrued Liabilities	22.93	1.32	1.18	0.86	1.04	0.79
Other Current Liabilities	3.52	3.33	4.97	4.22	0.02	0.00
Total Current Liabilities	34.81	12.13	14.26	12.91	6.29	5.78
Non-Current Liabilities
Long-Term Debt	10.16	10.68	8.52	6.32	6.26	7.62
Other Non-Current Liabilities	0.69	19.44	19.47	18.41	19.23	18.29
Total Non-Current Liabilities	10.87	30.76	28.06	25.47	26.46	26.27
Total Liabilities	45.68	42.89	42.32	38.38	32.76	32.05
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-37.75	-33.08	-30.06	-25.66	-19.03	-14.83
Accumulated Other Comprehensive Income	0.68	1.12	0.55	0.59	0.27	0.19
Treasury Stock	16.37	16.37	16.37	16.37	16.37	-
Additional Paid-in Capital	12.16	11.81	11.81	11.81	11.81	-4.56
Shares Outstanding	74.23	76.03	76.03	76.03	76.03	-
Total Stockholders' Equity	-24.91	-36.52	-34.07	-29.63	-23.33	-19.20
Total Liabilities & Equity	20.78	6.37	8.25	8.75	9.43	12.84

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Jyong Biotech Balance Sheet

How much debt does Jyong Biotech have?

Jyong Biotech had total debt of $17.87M as of Dec 31, 2025, against $1.18M in cash and short-term investments. Total debt was $17.96M a year earlier.

What are Jyong Biotech's total assets?

Jyong Biotech reported total assets of $20.78M as of Dec 31, 2025, up 226.4% from $6.37M a year earlier. Total liabilities were $45.68M.

What is Jyong Biotech's shareholders' equity?

Jyong Biotech's shareholders' equity was negative at −$24.91M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition